Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCDInT: Screening and Intervention for CHD with Diabetes
NCT05782881Recruiting
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms). Primary endpoint: Composite cardiovascular disease at 1 year. Started Jan 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05782881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05782881.